Showing 2141-2150 of 9299 results for "".
Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-38/23774/Women in Dermatology With S. Manjula Jegasothy, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-with-s-manjula-jegasothy-md/23173/Currents
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/currents-6/23145/Get More of the Patients You Want
https://practicaldermatology.com/topics/practice-management/get-more-of-the-patients-you-want/20520/How to use micro-targeted digital marketing to grow your practice.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-18/23367/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20790/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20477/Psoriasis Therapeutics and Moving to Private Practice
https://practicaldermatology.com/series/the-practical-dermatology-podcast/program-name/35733/H.L. Greenberg, MD, discusses his recent Practical Dermatology article on the various benefits of different psoriasis therapeutics, and Tina Bhutani, MD, MAS, FAAD, joins Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, to discuss the transition from academia to private practice and playPractical Dermatology Roundtable: Generalized Pustular Psoriasis, Ch. 1
https://practicaldermatology.com/series/the-practical-dermatology-roundtable/practical-dermatology-roundtable-generalized-pustular-psoriasis-ch-1/32757/In the first installment of a six-part series, host Neal Bhatia, MD, FAAD, and guests Jason E. Hawkes, MD, MS, FAAD, and Laura K. Ferris, MD, PhD, FAAD, provide an overview of generalized pustular psoriasis, including the unique challenges it poses, triggers associated with it, and the importance ofDermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-3-year-clinical-data-lebrikizumab/28648/Study author Melinda Gooderham, MSc, MD, FRCPC, discusses the new three-year clinical data presented at the European Academy of Dermatology & Venereology (EADV) Congress on the efficacy and safety of lebrikizumab, which the FDA recently approved on September 13 for adults and adolescents with mo